Endo Inc. Sustainability Profile
Endo Inc., a prominent player in the pharmaceutical and medical device industry, is headquartered in the United States. Founded in 1997, the company has established itself as a leader in pain management, urology, and other therapeutic areas, with a strong operational presence across North America and Europe. Endo Inc. is renowned for its innovative products, including advanced pain relief medications and minimally invasive surgical devices, which are designed to improve patient outcomes. The company’s commitment to quality and efficacy has earned it a significant market position, marked by notable achievements in research and development. With a focus on addressing unmet medical needs, Endo Inc. continues to drive advancements in healthcare, making a meaningful impact on patients' lives.
DitchCarbon Score
How does Endo Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Endo Inc.'s score of 27 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Endo Inc.'s reported carbon emissions
In 2024, Endo Inc. reported total carbon emissions of approximately 14,557,000 kg CO2e for Scope 1 and about 49,401,000 kg CO2e for Scope 2. This marks a slight increase in emissions from 2023, where Scope 1 emissions were about 13,435,000 kg CO2e and Scope 2 emissions were approximately 45,570,000 kg CO2e. Over the past few years, the company has seen fluctuations in its emissions, with 2022 figures showing Scope 1 emissions at about 12,718,000 kg CO2e and Scope 2 at approximately 36,208,000 kg CO2e. Endo Inc. has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further development in their sustainability strategy. As a current subsidiary of Endo Inc., emissions data is cascaded from the parent company, reflecting their overall corporate responsibility approach. The company has not publicly committed to any specific climate pledges or initiatives such as SBTi or CDP, indicating potential areas for improvement in their climate action framework.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 27,475,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 37,395,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
How Carbon Intensive is Endo Inc.'s Industry?
How Carbon Intensive is Endo Inc.'s Location?
Endo Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Endo Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
